Kohlberg Kravis Roberts & Co’s AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 APCA.WS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-12,500
Closed -$2K 228
2022
Q2
$2K Hold
12,500
﹤0.01% 246
2022
Q1
$3K Buy
+12,500
New +$3.62K ﹤0.01% 263

Other funds holding APCA.WS

Kohlberg Kravis Roberts & Co's APCA.WS Position: Q3 2022 in Review

Kohlberg Kravis Roberts & Co sold out of AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 (APCA.WS) in Q3 2022, closing a stake of 12,500 shares — an estimated $2K sold.

Kohlberg Kravis Roberts & Co first reported a position in APCA.WS in Q1 2022 and held it in 2 quarters. The position peaked at $3K in Q1 2022. 35 funds tracked by Wall St. Rank hold APCA.WS as of Q3 2022.

  • Kohlberg Kravis Roberts & Co reported no remaining AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position as of Q3 2022 after selling out during the quarter.
  • Kohlberg Kravis Roberts & Co sold 12,500 AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 shares in Q3 2022, an estimated $2K.
  • Kohlberg Kravis Roberts & Co first reported a position in AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 in Q1 2022 and held it in 2 quarters.
  • Kohlberg Kravis Roberts & Co's AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 position peaked at $3K in Q1 2022.
  • 35 funds tracked by Wall St. Rank held AP Acquisition Corp Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 as of Q3 2022.

Based on Kohlberg Kravis Roberts & Co's 13F filing for Q3 2022, filed 14 Nov 2022.